de Figueiredo A, Simas C, Karafillakis E, Paterson P, Larson HJ Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study. Lancet. 2020 Sep 26;396(10255):898-908. doi: 1
Devlin J, Chang M-W, Lee K, et al Bert: Pre-training of deep bidirectional transformers for language understanding. arXiv preprint, 2018, arXiv:181004805.
Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007-2012. Vaccine. 2014 Apr 17;32(19):2150-9. doi: 10.1016/j.vaccine.2014.01.081. Epub 2014 Mar 2. Review.
Milinovich GJ, Williams GM, Clements AC, Hu W Internet-based surveillance systems for monitoring emerging infectious diseases. Lancet Infect Dis. 2014 Feb;14(2):160-8. doi: 10.1016/S1473-3099(13)70244-5. Epub 2013 Nov 28. Review.
Zhao N, Jiao D, Bai S, Zhu T Evaluating the Validity of Simplified Chinese Version of LIWC in Detecting Psychological Expressions in Short Texts on Social Network Services. PLoS One. 2016 Jun 20;11(6):e0157947. doi: 10.1371/journal.pone.0157947. eCollection 2016.
A Social Media-based Machine Learning Study to Monitor Vaccine Confidence and Hesitancy and Early Warn Emerging Vaccine-related Risks in Real Time
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.